Relmada Therapeutics, Inc. RLMD Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s common stock?
- Relmada Therapeutics, Inc. (RLMD) reported common stock of 150M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s common stock changed year-over-year?
- Relmada Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from 150M to 150M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s common stock has grown at a 24.6% compound annual growth rate (CAGR), from 50M to 150M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).